X

Suven pharmaceuticals Q3FY23 net profit drops by 33 percent

The company has reported total income of INR 366.78 crores during the period ended December 31, 2022 as compared to INR 456.27 crores during the period ended December 31, 2021, depicting a fall of 19.6%.

The company has posted net profit of INR 107.72 crores for the period ended December 31, 2022 as against net profit of INR 160.06 crores for the period ended December 31, 2021.The company has reported EPS of INR 4.23 for the period ended December 31, 2022 as compared to INR 6.29 for the period ended December 31, 2021.

Related Post